iShares Genomics Immunology and Healthcare ETF
IDNA----
Portfolio
Oct 9, 2026- Stock99.67%
- Cash0.33%
Morningstar style box
Oct 9, 2026Current style: Mid Blend
Large
Mid
Small
12%
14%
0%
6%
26%
1%
8%
20%
13%
ValueBlendGrowth
Weight %50+25-4910-240-9
Top Holdings
Oct 9, 2026Top 10 Holdings Weight: 49.0%
| Name/code | Weight | Type | Industry | Style | Price | Change % | Market Cap |
|---|---|---|---|---|---|---|---|
| 13.23% | Equity | Health Care | Large Blend | — | — | — | |
| 6.44% | Equity | Health Care | Mid Blend | — | — | — | |
| 4.96% | Equity | Health Care | Small Growth | — | — | — | |
4  Genmab AS | 4.14% | — | — | — | — | — | — |
| 3.55% | Equity | Health Care | Mid Blend | — | — | — | |
| 3.46% | Equity | Health Care | Mid Blend | — | — | — | |
| 3.36% | Equity | Health Care | Large Blend | — | — | — | |
8 Takeda Pharmaceutical Co Ltd | 3.35% | — | — | — | — | — | — |
| 3.28% | Equity | Health Care | Large Value | — | — | — | |
| 3.27% | Equity | Health Care | Large Value | — | — | — |
